Article Dans Une Revue Anaesthesia Critical Care & Pain Medicine Année : 2026

Influence of CYP2D6 phenotype on the pharmacokinetics and pharmacodynamics of tramadol in patients treated for post-operative pain management

Nathalie Bleyzac
  • Fonction : Auteur

Résumé

Introduction: Tramadol is widely used in post-operative pain management. Concentrations of tramadol and its active metabolite O-demethyl tramadol (O-dT) are influenced by cytochrome P450 2D6 (CYP2D6) genotype. Objectives: The objectives of this study were to investigate the relationships between CYP2D6 phenotype and tramadol pharmacokinetics/ pharmacodynamics (PK/PD) in real life setting. Methods: CYTRAM was a prospective multicenter study conducted in patients who received post-operative intravenous (IV) tramadol. Patients underwent CYP2D6 genotyping and phenotyping as well as tramadol and O-dT concentration measurements at 24 h and 48 h of therapy. A PK model was used to estimate tramadol and O-dT area under the concentration-time curve (AUC). Pain rating was performed at 24 h and 48 h and evaluated by Numeric Rating Scale (NRS). Patients with NRS < 4 were classified as responders. Variables associated with analgesic response were examined. Results: PK data from 285 patients and pain scores from 273 and 204 patients were available at 24 h and 48 h, respectively. Mean AUC of O-dT was two-fold lower in CYP2D6 poor metabolizers (PM) compared with subjects with other phenotypes (non-PM). At 48 h, pain scores were significantly higher in PM than in non-PM patients. In addition, PM subjects exhibited a significantly lower rate of response (50% versus 78%) and a higher rate of morphine use (47% versus 17%) at 48 h compared with non-PM subjects. However, CYP2D6 phenotype was not an independent predictor of response in the entire population. Conclusion: Our results support current pharmacogenetic guidelines and suggest avoiding tramadol for postoperative management in patients with known CYP2D6 PM phenotype. Registration: ClinicalTrials.gov (NCT00952159).

Fichier non déposé

Dates et versions

hal-05582207 , version 1 (07-04-2026)

Identifiants

Citer

Soizic Percevault, Blandine de la Gastine, Laurent Varin, Nicolas Richard, Fabienne Fobe, et al.. Influence of CYP2D6 phenotype on the pharmacokinetics and pharmacodynamics of tramadol in patients treated for post-operative pain management. Anaesthesia Critical Care & Pain Medicine, 2026, pp.101781. ⟨10.1016/j.accpm.2026.101781⟩. ⟨hal-05582207⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

  • More